4//SEC Filing
Weis Holger 4
Accession 0000950170-25-094383
CIK 0001107421other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 7:08 PM ET
Size
5.8 KB
Accession
0000950170-25-094383
Insider Transaction Report
Form 4
Weis Holger
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-07-02+130,000→ 130,000 totalExercise: $5.02Exp: 2035-07-01→ Common Stock (130,000 underlying)
Footnotes (1)
- [F1]25% of this grant will vest and become exercisable immediately upon grant and the remaining balance shall vest in substantially equal quarterly installments over a three year period commencing on the Start Date with the first vesting date being October 2, 2025, subject to holder's continuous employment through each vesting date. This option grant shall be subject to the terms and conditions of the Company's 2020 Equity Incentive Plan and a Stock Option Agreement.
Documents
Issuer
Alaunos Therapeutics, Inc.
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001846984
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 7:08 PM ET
- Size
- 5.8 KB